Exoproteome and Secretome Derived Broad Spectrum Novel Drug and Vaccine Candidates in Vibrio cholerae Targeted by Piper betel Derived Compounds

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Barh, Debmalya ^a,b   Barve, Neha ^a,c   Gupta, Krishnakant ^a,c   Chandra, Sudha ^a,c   Jain, Neha ^a   Tiwari, Sandeep ^a   Leon Sicairos, Nidia ^d   Canizalez Roman, Adrian ^d   Rodrigues dos Santos, Anderson ^e   Hassan, Syed Shah ^e   Almeida, Síntia ^e   Thiago Jucá Ramos, Rommel ^f   Augusto Carvalho de Abreu, Vinicius ^e   Ribeiro Carneiro, Adriana ^f   de Castro Soares, Siomar ^e   Luiz de Paula Castro, Thiago ^e   Miyoshi, Anderson ^e   Silva, Artur ^f   Kumar, Anil ^c   Misra, Amarendra Narayan ^b,g   Blum, Kenneth ^a,h,i   Braverman, Eric R ^j   Azevedo, Vasco ^e   more..

^a Institute of Integrative Omics and Applied Biotechnology IIOAB   (India)

^b FAKIR MOHAN UNIVERSITY   (India)

^c DEVI AHILYA UNIVERSITY   (India)

^d UNIVERSIDAD AUTÓNOMA DE SINALOA   (Mexico)

^e FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^f FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^g CENTRAL UNIVERSITY OF JHARKHAND   (India)

^h UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

ⁱ UNIVERSITY OF VERMONT   (United States)

^j WEILL CORNELL MEDICAL COLLEGE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL VACCINE; EPITOPE; EXOPROTEOME; MICROORGANISM PROTEIN; OMPU PROTEIN; PEPTIDE VACCINE; SECRETOME; UNCLASSIFIED DRUG; UPPP PROTEIN; YAJC PROTEIN;

ARTICLE; B LYMPHOCYTE; BACTERIAL GENOME; BACTERIAL VIRULENCE; CELLULAR IMMUNITY; COMPARATIVE STUDY; CONTROLLED STUDY; FUNCTIONAL PROTEOMICS; GENETIC SCREENING; GENOME ANALYSIS; HOST PATHOGEN INTERACTION; HUMAN; MOLECULAR MODEL; NONHUMAN; PIPER BETLE; PROTEIN DETERMINATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SEQUENCE ANALYSIS; T LYMPHOCYTE; VIBRIO CHOLERAE;

CHOLERA; DRUG DISCOVERY; EPITOPES, T-LYMPHOCYTE; HUMANS; LIGANDS; PIPER BETLE; PROTEOME; SMALL MOLECULE LIBRARIES; VACCINES, SUBUNIT; VIBRIO CHOLERAE;

EID: 84873864473     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052773     Document Type: Article

References (82)

1. Sack DA, Sack RB, Nair GB, Siddique AK, (2004) Cholera. Lancet 363 (9404): 223-233.
2. Shimada T, Sakazaki R, (1977) Additional serovars and inter-O antigenic relationships of V. cholerae. Jpn J Med Sci Biol. 30 (5): 275-277.
3. Faruque SM, Albert MJ, Mekalanos JJ, (1998) Epidemiology, genetics, and ecology of toxigenic Vibrio cholerae. Microbiol Mol Biol Rev. 62 (4): 1301-1314.
4. Siddique AK, Zaman K, Baqui AH, Akram K, Mutsuddy P, et al. (1992) Cholera epidemics in Bangladesh: 1985-1991. J Diarrhoeal Dis Res. 10 (2): 79-86.
5. Siddique AK, Akram K, Zaman K, Mutsuddy P, Eusof A, et al. (1996) Vibrio cholerae O139: how great is the threat of a pandemic? Trop Med Int Health. 1 (3): 393-398.
6. Fazil MH, Singh DV, (2011) Vibrio cholerae infection, novel drug targets and phage therapy. Future Microbiol. 6 (10): 1199-1208.
7. Mandal S, Mandal MD, Pal NK, (2011) Cholera: a great global concern. Asian Pac J Trop Med. 4 (7): 573-580.
8. Tran HD, Alam M, Trung NV, Kinh NV, Nguyen HH, et al. (2012) Multi-drug resistant Vibrio cholerae O1 variant El Tor isolated in northern Vietnam between 2007 and 2010. J Med Microbiol. 61(3): 431-437.
9. Barh D, Tiwari S, Jain N, Ali A, Santos AR, et al. (2011) In silico subtractive genomics for target identification in human bacterial pathogens. Drug Dev Res. 72: 162-177.
10. Pizza M, Scarlato V, Masignani V, Giuliani MM, Aricò B, et al. (2000) Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 287 (5459): 1816-1820.
11. Agüero F, Al-Lazikani B, Aslett M, Berriman M, Buckner FS, et al. (2008) Genomic-scale prioritization of drug targets: the TDR Targets database. Nat Rev Drug Discov 7: 900-907.
12. Caffrey CR, Rohwer A, Oellien F, Marhöfer RJ, Braschi S, et al. (2009) A comparative chemogenomics strategy to predict potential drug targets in the metazoan pathogen, Schistosoma mansoni. PLoS One 4(2): e4413.
13. Crowther GJ, Shanmugam D, Carmona SJ, Doyle MA, Hertz-Fowler C, et al. (2010) Identification of attractive drug targets in neglected-disease pathogens using an in silico approach. PLoS Negl Trop Dis 4: e804.
14. Abadio AK, Kioshima ES, Teixeira MM, Martins NF, Maigret B, et al. (2011) Comparative genomics allowed the identification of drug targets against human fungal pathogens. BMC Genomics 12: 75.
15. Barh D, Jain N, Tiwari S, Parida BP, D'Afonseca V, et al. (2011) A novel comparative genomics analysis for common drug and vaccine targets in Corynebacterium pseudotuberculosis and other CMN group of human pathogens. Chem Biol Drug. 78 (1): 73-84.
16. Barh D, Misra AN, Kumar A, Azevedo V, (2010) A novel strategy of epitope design in Neisseria gonorrhoeae. Bioinformation 5 (2): 77-85.
17. Yu CS, Lin CJ, Hwang JK, (2004) Predicting subcellular localization of proteins for Gram-negative bacteria by support vector machines based on n-peptide compositions. Protein Sci. 13 (5): 1402-1406.
18. Bhasin M, Garg A, Raghava GP, (2005) PSLpred: prediction of subcellular localization of bacterial proteins. Bioinformatics 21: 2522-2524.
19. Gardy JL, Laird MR, Chen F, Rey S, Walsh CJ, et al. (2005) PSORTb v.2.0: expanded prediction of bacterial protein subcellular localization and insights gained from comparative proteome analysis. Bioinformatics 21: 617-623.
20. Imai K, Asakawa N, Tsuji T, Akazawa F, Ino A, et al. (2008) SOSUI-GramN: high performance prediction for sub-cellular localization of proteins in Gram-negative bacteria. Bioinformation 2: 417-421.
21. Barinov A, Loux V, Hammani A, Nicolas P, Langella P, et al. (2009) Prediction of surface exposed proteins in Streptococcuspyogenes, with a potential application to other Gram-positive bacteria. Proteomics 9: 61-73.
22. Zhang R, Lin Y, (2009) DEG 5.0, a database of essential genes in both prokaryotes and eukaryotes. Nucleic Acids Res. 37: D455-D458.
23. Gish W, States JD, (1993) Identification of protein coding regions by database similarity search. Nat Genet. 3: 266-272.
24. Rocha EP, Danchin A, (2003) Essentiality, not expressiveness, drives gene-strand bias in bacteria. Nat Genet 34: 377-378.
25. Gao F, Zhang CT, (2008) Ori-Finder: a web-based system for finding oriCs in unannotated bacterial genomes. BMC Bioinformatics 9: 79.
26. Vetrivel U, Arunkumar V, Dorairaj S, (2007) ACUA: a software tool for automated codon usage analysis. Bioinformation 2: 62-63.
27. Schomburg I, Chang A, Schomburg D, (2002) BRENDA, enzyme data and metabolic information.Nucleic Acids Res. 30(1): 47-9.
28. Magrane M, Consortium U, (2011) UniProt Knowledgebase: a hub of integrated protein data. Database (Oxford). 2011: bar009.
29. Lin Y, Gao F, Zhang CT, (2010) Functionality of essential genes drives gene strand-bias in bacterial genomes. Biochem Biophys Res Commun 396: 472-476.
30. Knox C, Law V, Jewison T, Liu P, Ly S, et al. (2011) DrugBank 3.0: a comprehensive resource for 'omics' research on drugs.Nucleic Acids Res. 39(Database issue): D1035-41.
31. Kouranov A, Xie L, de la Cruz J, Chen L, Westbrook J, et al. (2006) The RCSB PDB information portal for structural genomics. Nucleic Acids Res. 34: D302-5.
32. Lin MY, Ottenhoff TH, (2008) Host-pathogen interactions in latent Mycobacterium tuberculosis infection: identification of new targets for tuberculosis intervention. Endocr Metab Immune Disord Drug Targets. 8 (1): 15-29.
33. Hu Z, Hung JH, Wang Y, Chang YC, Huang CL, et al. (2009) VisANT 3.5: multi-scale network visualization, analysis and inference based on the gene ontology. Nucleic Acids Res. 37: W115-21.
34. Kanehisa M, Goto S, (2000) KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28: 27-30.
35. Gillespie JJ, Wattam AR, Cammer SA, Gabbard JL, Shukla MP, et al. (2011) PATRIC: the comprehensive bacterial bioinformatics resource with a focus on human pathogenic species. Infect. Immun. 79: 4286-4298.
36. Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, et al. (2011) The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 39: D561-568.
37. Huang DW, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources. Nature Protoc 4 (1): 44-57.
38. Doytchinova IA, Flower DR, (2007) VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinformatics 8: 4.
39. Garg A, Gupta D, (2008) VirulentPred: a SVM based prediction method for virulent proteins in bacterial pathogens. BMC Bioinformatics 9: 62.
40. Krogh A, Larsson B, von Heijne G, Sonnhammer EL, (2001) Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol 305(3): 567-580.
41. El-Manzalawy Y, Dobbs D, Honavar V, (2008) Predicting linear B-cell epitopes using string kernels. J Mol Recognit. 21(4): 243-255.
42. Singh H, Raghava GP, (2001) ProPred: prediction of HLA-DR binding sites. Bioinformatics 17(12): 1236-7.
43. Singh H, Raghava GP, (2003) ProPred1: prediction of promiscuous MHC Class-I binding sites. Bioinformatics 19(8): 1009-1014.
44. Guan P, Doytchinova IA, Zygouri C, Flower DR, (2003) MHCPred: A server for quantitative prediction of peptide-MHC binding, Nucleic Acids Res. 31(13): 3621-3624.
45. Kangueane P, Sakharkar MK, (2005) T-Epitope Designer: A HLA-peptide binding prediction server. Bioinformation 1(1): 21-4.
46. Kelley LA, Sternberg MJ, (2009) Protein structure prediction on the Web: a case study using the Phyre server. Nat Protoc. 4(3): 363-371.
47. Roy A, Kucukural A, Zhang Y, (2010) I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc. 5(4): 725-738.
48. Fiser A, Sali A, (2003) ModLoop: automated modeling of loops in protein structures. Bioinformatics 19(18): 2500-2501.
49. Colovos C, Yeates TO, (1993) Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci. 2(9): 1511-1519.
50. Lovell SC, Davis IW, Arendall WB 3rd, de Bakker PI, Word JM, et al (2003) Structure validation by Calpha geometry: phi,psi and Cbeta deviation. Proteins 50(3): 437-450.
51. Holm L, Rosenström P, (2010) Dali server: conservation mapping in 3D. Nucleic Acids Res. 38: W545-9.
52. Mayrose I, Penn O, Erez E, Rubinstein ND, Shlomi T, et al. (2007) Pepitope: epitope mapping from affinity-selected peptides. Bioinformatics 23(23): 3244-3246.
53. Thomsen R, Christensen MH, (2006) MolDock: A New Technique for High-Accuracy Molecular Docking. J Med Chem. 49(11): 3315-3321.
54. Dundas J, Ouyang Z, Tseng J, Binkowski A, Turpaz Y, et al. (2006) CASTp: computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues.Nucleic Acids Res. 34: W116-8.
55. Hendlich M, Rippmann F, Barnickel G, (1997) LIGSITE: automatic and efficient detection of potential small molecule-binding sites in proteins. J Mol Graph Model. 15(6): 359-363.
56. Singh T, Biswas D, Jayaram B, (2011) AADS-an automated active site identification, docking, and scoring protocol for protein targets based on physicochemical descriptors. J Chem Inf Model. 51(10): 2515-2527.
57. Verdonk ML, Cole JC, Hartshorn MJ, Murray CW, Taylor RD, (2003) Improved protein-ligand docking using GOLD. Proteins 52(4): 609-623.
58. Kim Y, Ponomarenko J, Zhu Z, Tamang D, Wang P, et al. (2012) Immune epitope database analysis resource. Nucleic Acids Res. 40: W525-30.
59. Hunt A, Rawlins JP, Thomaides HB, Errington J, (2006) Functional analysis of 11 putative essential genes in Bacillus subtilis. Microbiology 152(10): 2895-2907.
60. Chaudhuri RR, Allen AG, Owen PJ, Shalom G, Stone K, et al. (2009) Comprehensive identification of essential Staphylococcus aureus genes using Transposon-Mediated Differential Hybridisation (TMDH). BMC Genomics 10: 291.
61. Shanmugam A, Natarajan J, (2010) Computational genome analyses of metabolic enzymes in Mycobacterium leprae for drug target identification. Bioinformation 4(9): 392-395.
62. Georrge JN, Umrania V, (2011) In silico identification of putative drug targets in Klebsiella pneumonia MGH78578. Indian Journal of Biotechnology 10: 432-439.
63. Duperthuy M, Schmitt P, Garzón E, Caro A, Rosa RD, et al. (2011) Use of ompU porins for attachment and invasion of Crassostrea gigas immune cells by the oyster pathogen Vibrio splendidus. Proc Natl Acad Sci U S A 108(7): 2993-2998.
64. Sperandio V, Bailey C, Girón JA, DiRita VJ, Silveira WD, et al. (1996) Cloning and characterization of the gene encoding the ompU outer membrane protein of Vibrio cholerae.Infect Immun. 64(12): 5406-5409.
65. Reddy GK, Rao KN, Prasad PR, (2011) Identification of drug and vaccine targets in Clostridium botulinum-A by the approach in-silico subtractive genomics. International Journal of Pharmaceutical Studies and Research 2: 48-54.
66. Magariños MP, Carmona SJ, Crowther GJ, Ralph SA, Roos DS, et al. (2012) TDR Targets: a chemogenomics resource for neglected diseases. Nucleic Acids Res. 40: D1118-27.
67. Liu B, Pop M, (2009) ARDB-Antibiotic Resistance Genes Database. Nucleic Acids Res. 37: D443-7.
68. Butt AM, Nasrullah I, Tahir S, Tong Y, (2012) Comparative Genomics Analysis of Mycobacterium ulcerans for the Identification of Putative Essential Genes and Therapeutic Candidates. PLoS One. 7(8): e43080.
69. Duffield M, Cooper I, McAlister E, Bayliss M, Ford D, et al. (2010) Predicting conserved essential genes in bacteria: in silico identification of putative drug targets. Mol Biosyst 6: 2482-2489.
70. Keller TH, Pichota A, Yin Z, (2006) A practical view of 'druggability'. Curr Opin Chem Biol 10: 357-361.
71. Dallo SF, Su CJ, Horton JR, Baseman JB, (1998) Identification of P1 gene domain containing epitope(s) mediating Mycoplasma pneumoniae cytoadherence. J Exp Med. 167(2): 718-723.
72. Valentão P, Gonçalves RF, Belo C, de Pinho PG, Andrade PB, et al. (2010) Improving the knowledge on Piper betle: targeted metabolite analysis and effect on acetylcholinesterase. J Sep Sci. 33(20): 3168-3176.
73. Ali I, Khan FG, Suri KA, Gupta BD, Satti NK, et al. (2010) In vitro antifungal activity of hydroxychavicol isolated from Piper betle L. Ann Clin Microbiol Antimicrob. 9: 7.
74. Sarkar A, Sen R, Saha P, Ganguly S, Mandal G, et al. (2008) An ethanolic extract of leaves of Piper betle (Paan) Linn mediates its antileishmanial activity via apoptosis. Parasitol Res. 102(6): 1249-1255.
75. Al-Adhroey AH, Nor ZM, Al-Mekhlafi HM, Amran AA, Mahmud R, (2010) Antimalarial activity of methanolic leaf extract of Piper betle L. Molecules. 16(1): 107-118.
76. Singh M, Shakya S, Soni VK, Dangi A, Kumar N, et al. (2009) The n-hexane and chloroform fractions of Piper betle L. trigger different arms of immune responses in BALB/c mice and exhibit antifilarial activity against human lymphatic filarid Brugia malayi. Int Immunopharmacol (b96):: 716-28.
77. Trakranrungsie N, Chatchawanchonteera A, Khunkitti W, (2008) Ethnoveterinary study for antidermatophytic activity of Piper betle, Alpinia galanga and Allium ascalonicum extracts in vitro. Res Vet Sci. 84(1): 80-84.
78. Wirotesangthong M, Inagaki N, Tanaka H, Thanakijcharoenpath W, Nagai H, (2008) Inhibitory effects of Piper betle on production of allergic mediators by bone marrow-derived mast cells and lung epithelial cells. Int Immunopharmacol. 8(3): 453-457.
79. Kanjwani DG, Marathe TP, Chiplunkar SV, Sathaye SS, (2008) Evaluation of immunomodulatory activity of methanolic extract of Piper betel. Scand J Immunol. 67(6): 589-593.
80. Majumdar B, Ray Chaudhuri SG, Ray A, Bandyopadhyay SK, (2003) Effect of ethanol extract of Piper betle Linn leaf on healing of NSAID-induced experimental ulcer-a novel role of free radical scavenging action. Indian J Exp Biol. 41(4): 311-315.
81. Dasgupta N, De B, (2004) Antioxidant activity of Piper betle L. leaf extract in vitro. Food Chem. 88: 219-224.
82. Ganguly S, Mula S, Chattopadhyay S, Chatterjee M, (2007) An ethanol extract of Piper betle Linn. mediates its anti-inflammatory activity via down-regulation of nitric oxide. J Pharm Pharmacol. 59(5): 711-718.